AU2003271098A1 - Hypoglycemic substances containing zinc - Google Patents

Hypoglycemic substances containing zinc

Info

Publication number
AU2003271098A1
AU2003271098A1 AU2003271098A AU2003271098A AU2003271098A1 AU 2003271098 A1 AU2003271098 A1 AU 2003271098A1 AU 2003271098 A AU2003271098 A AU 2003271098A AU 2003271098 A AU2003271098 A AU 2003271098A AU 2003271098 A1 AU2003271098 A1 AU 2003271098A1
Authority
AU
Australia
Prior art keywords
containing zinc
substances containing
hypoglycemic substances
hypoglycemic
zinc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003271098A
Inventor
Naemi Kajiwara
Yoshitane Kojima
Hiromu Sakurai
Hiroshi Taniguchi
Yutaka Yoshikawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2003271098A1 publication Critical patent/AU2003271098A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4425—Pyridinium derivatives, e.g. pralidoxime, pyridostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
AU2003271098A 2002-10-18 2003-10-03 Hypoglycemic substances containing zinc Abandoned AU2003271098A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2002304751 2002-10-18
JP2002-304751 2002-10-18
JP2003-315857 2003-09-08
JP2003315857A JP2004155766A (en) 2002-10-18 2003-09-08 Zinc-containing substance having blood sugar level-lowering activity
PCT/JP2003/012741 WO2004035065A1 (en) 2002-10-18 2003-10-03 Hypoglycemic substances containing zinc

Publications (1)

Publication Number Publication Date
AU2003271098A1 true AU2003271098A1 (en) 2004-05-04

Family

ID=32109484

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003271098A Abandoned AU2003271098A1 (en) 2002-10-18 2003-10-03 Hypoglycemic substances containing zinc

Country Status (3)

Country Link
JP (1) JP2004155766A (en)
AU (1) AU2003271098A1 (en)
WO (1) WO2004035065A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7736676B2 (en) * 2003-05-14 2010-06-15 Indus Biotech Pvt. Ltd. Synergistic composition for the treatment of diabetes mellitus
DE10324282A1 (en) * 2003-05-28 2004-12-16 Bayer Healthcare Ag Combination of acetylsalicylic acid and alpha-glucosidase inhibitors
FR2901274B1 (en) * 2006-05-19 2010-09-17 Coordination De Rech S Therape NOVEL METAL COMPLEXES, PROCESS FOR THEIR PREPARATION AND THEIR THERAPEUTIC USE
EP2347821B1 (en) * 2008-09-29 2016-09-21 NGK Insulators, Ltd. Gas adsorbing material, precursor of the gas adsorbing material, and process for producing gas adsorbing material
EP2349264A1 (en) * 2008-11-17 2011-08-03 Technische Universität München Pyrimidinium derivatives for use in the treatment or prevention of diabetes
CN110776420B (en) * 2019-11-18 2022-04-26 山东省化工研究院 Synthesis process of carbasalate calcium
CA3162362A1 (en) 2019-12-20 2021-06-24 Vector Vitale Ip Llc Composition and method for the prevention and treatment of type 2 diabetes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU172831B (en) * 1976-03-31 1978-12-28 Egyt Gyogyszervegyeszeti Gyar Process for producing complex compounds of oligo- and polygalacturonic acids with essential metal ions
WO1987001281A1 (en) * 1985-08-27 1987-03-12 Glyzinc Pharmaceuticals Limited Zinc glycerolate complex and additions for pharmaceutical applications
JP2001220348A (en) * 1999-11-30 2001-08-14 Japan Science & Technology Corp Hypoglycemic comprising zinc (ii) organic complex
JP2003040784A (en) * 2001-01-31 2003-02-13 Japan Science & Technology Corp Hypoglycemic agent
JP2003199532A (en) * 2001-12-28 2003-07-15 Junichi Arita Food comprising zinc organic composition
JP2003319760A (en) * 2002-02-26 2003-11-11 Junichi Arita Zinc-containing substance having anti-obesity function

Also Published As

Publication number Publication date
WO2004035065A1 (en) 2004-04-29
JP2004155766A (en) 2004-06-03

Similar Documents

Publication Publication Date Title
AU2003206642A1 (en) Lid element
AU2003237233A1 (en) Improved receptacle
AU2003220987A1 (en) Chemical container
AU2003266949A1 (en) Compounds
AU2003221098A1 (en) Oligofluorenylene compounds
AU2003279366A1 (en) Novel compounds
AU2003215209A1 (en) Syringe
AU2003232536A1 (en) Microcapsules containing biomedical materials
AU2003287178A1 (en) Chemical compounds
AU2003271626A1 (en) Container
AU2003259457A1 (en) Auto-destructible syringe
AU2003226659A1 (en) Barrier-protected container
AU2003230787A1 (en) Smoking-waste receptacle
AU2003290661A1 (en) Chemical compounds
AU2003302904A1 (en) Container
AU2003254239A1 (en) Container assembly
AU2003216859A1 (en) Amidoacetonitrile compounds
AU2003284217A1 (en) Chemical compounds
AU2003271098A1 (en) Hypoglycemic substances containing zinc
AU2003211586A1 (en) Drugs containing riboflavin-type compounds
AU2003251389A1 (en) Disposable multicup container
AU2003255727A1 (en) Syringes
AU2003264792A1 (en) Container
AU2003292667A1 (en) Benzocycloheptapyridine compounds
AU2003251259A1 (en) Novel compounds

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase